v3.25.1
NET LOSS PER SHARE
3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
NET LOSS PER SHARE

10) NET LOSS PER SHARE

 

The Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required for participating securities. The Company’s previously issued convertible notes contractually entitled the holders of such notes to participate in dividends but did not contractually require the holders to participate in the Company’s losses. As such, the two-class method is not applicable during periods with a net loss.

 

Basic net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, including the weighted average effect of prefunded warrants, and without consideration for potentially dilutive securities.

 

Diluted net loss per share is calculated by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding, including the weighted average effect of the prefunded warrants, plus dilutive securities. Shares of common stock issuable upon exercise, conversion or vesting of stock options, restricted stock units, warrants and the outstanding Series A convertible preferred stock are considered potential shares of common stock and are included in the calculation of diluted net loss per share using the treasury method when their effect is dilutive. The Company’s convertible notes that were outstanding as of March 31, 2024 were also considered potential shares of common stock for the three months ended March 31, 2024 and were included in the calculation of diluted net loss per share using the “if-converted” method as of such period, and the more dilutive of either the two-class method or the if-converted method was reported. There were no convertible notes outstanding as of March 31, 2025. Diluted net loss per share is the same as basic net loss per share for periods in which the effect of potentially dilutive shares of common stock is antidilutive.

 

The following table presents the number of shares subject to outstanding warrants, stock options, RSUs, convertible notes and Series A convertible preferred stock that were excluded from the computation of diluted net loss per share of common stock for the three months ended March 31, 2025 and 2024, as their effect was anti-dilutive (in thousands):

 

       
   Three months ended March 31, 
   2025   2024 
Stock options   4,460    2,085 
Warrants   484    20,386 
Preferred stock converted into common stock   68    19 
Convertible Notes converted into common stock   -    7,945 
RSUs   -    1 
Total potential common shares excluded from computation   5,012    30,436